Loading...
Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
INTRODUCTION: Phosphorylated tau (p‐tau) in cerebrospinal fluid (CSF) is an established Alzheimer's disease (AD) biomarker. Novel immunoassays targeting N‐terminal and mid‐region p‐tau181 and p‐tau217 fragments are available, but head‐to‐head comparison in clinical settings is lacking. METHODS:...
Na minha lista:
| Udgivet i: | Alzheimers Dement |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246793/ https://ncbi.nlm.nih.gov/pubmed/33252199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.12236 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|